Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

969083

registered interest
date	06/09/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Radiotherapy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the effect of levels of funding on the ability of the NHS to increase access to radiotherapy.
tabling member constituency	Easington
tabling member printed	Grahame Morris
uin	171339
answer	answer is ministerial correction date of answer 11/09/2018 answer text <p>Since 2016, the Radiotherapy Modernisation programme has seen £130 million of new funding invested in improving radiotherapy equipment. As a result, the National Health Service has so far received 73 new or upgraded linear accelerators, enabling the delivery of advanced treatment techniques and faster treatment times. From April 2019, NHS England will be establishing 11 Radiotherapy Networks to build on this investment and lead the development of services at a local level. This will include ensuring that every patient benefits from best clinical practice and has access to innovative and advanced treatments and techniques.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 11/09/2018 15:02:53 answering member 4067 label Biography information for Steve Brine
tabling member	3973 label Biography information for Grahame Morris

969086

registered interest
date	06/09/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Radiotherapy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how NHS England monitors clinical commissionng groups' cancer treatment performance in respect of access to advanced radiotherapy; and what steps NHS England takes to address instances of poor performance.
tabling member constituency	Easington
tabling member printed	Grahame Morris
uin	171340
answer	answer is ministerial correction date of answer 11/09/2018 answer text <p>Clinical commissioning groups are not responsible for ensuring access to advanced radiotherapy techniques, such as Intensity Modulated Radiotherapy (IMRT). The commissioning of all radiotherapy in England is the responsibility of NHS England’s Specialised Commissioning team. Access to IMRT is monitored against a national average access standard of 25%, performance against this standard is consistently around 45%. From April 2019, Radiotherapy Networks, working in close partnership with Specialised Commissioners and Cancer Alliances, will play a key role in increasing access to both advanced and innovative radiotherapy, as well as ensuring adherence to best practice treatment protocols.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 170800 question first answered 11/09/2018 14:23:08 answering member 4067 label Biography information for Steve Brine
tabling member	3973 label Biography information for Grahame Morris

968146

registered interest
date	05/09/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Radiotherapy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of the performance of Clinical Commissioning Groups to improve access to advanced radiotherapy.
tabling member constituency	Easington
tabling member printed	Grahame Morris
uin	170800
answer	answer is ministerial correction date of answer 11/09/2018 answer text <p>Clinical commissioning groups are not responsible for ensuring access to advanced radiotherapy techniques, such as Intensity Modulated Radiotherapy (IMRT). The commissioning of all radiotherapy in England is the responsibility of NHS England’s Specialised Commissioning team. Access to IMRT is monitored against a national average access standard of 25%, performance against this standard is consistently around 45%. From April 2019, Radiotherapy Networks, working in close partnership with Specialised Commissioners and Cancer Alliances, will play a key role in increasing access to both advanced and innovative radiotherapy, as well as ensuring adherence to best practice treatment protocols.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 171340 question first answered 11/09/2018 14:23:08 answering member 4067 label Biography information for Steve Brine
tabling member	3973 label Biography information for Grahame Morris